SLSSTOCK_USDT
币种名称 SLSSTOCK
流通率 0.00%
交易规则 (SLSUSDT Perpetual)
杠杆倍数 1 ~ 20
最小下单数量 1.273 USDT
市价单单笔最大下单数量 821.085 USDT
限价单单笔最大下单数量 821.085 USDT
最小变动价位 0.01
限价订单价格上限/下限比例 10% / 10%
最大挂单数量 50
价差保护阈值 10%
合约面值 1 张 = 0.1 SLS
强平手续费率 0.02%
查看所有合约交易规则基于各类指标等数据计算得到的分析，用于辅助判断买入和卖出信号。
数值指标
| 名称 | 数值 | 操作 |
|---|
| KDJ (9,3,3)_K | 82.2026 | 卖出 |
| KDJ (9,3,3)_D | 77.6694 | 卖出 |
| KDJ (9,3,3)_J | 91.2688 | 卖出 |
| RSI (14) | 56.8189 | 卖出 |
| StochRSI (%K) | 99.2885 | 卖出 |
| StochRSI (%D) | 97.7309 | 卖出 |
多维度指标
| 名称 | 操作 |
|---|
| KDJ (9,3,3)_K&D | 卖出 |
| KDJ (9,3,3) 金叉死叉 | 买入 |
| MACD (12,26,9) 金叉死叉 | 买入 |
| DEA 穿过零轴 | 卖出 |
| BOLL (20,2) 超买超卖 | 中立 |
| BOLL (20,2) 中轨金叉死叉 | 买入 |
总结: 卖出 8 · 中立 1 · 买入 17 — 买入
简介
SEELAS Life Sciences Group, Inc. was incorporated in the State of Delaware on April 3, 2006, as Gold Rush Pharmaceuticals, Inc., and changed its name to REX Pharmaceuticals, Inc. on November 28, 2006. On September 26, 2011, the company changed its name to Galena Biopharmaceuticals, Ltd. Galena is a biotechnology company focused on discovering, developing, and commercializing innovative therapies to address major medical needs using targeted biologic therapies. Galena is pursuing the development of novel cancer therapeutics using peptide-based immunotherapy products, including its lead product candidate, the peptide (E75), for the treatment of breast cancer and other tumors. In patients with low-to-intermediate HER2-positive breast cancer who do not qualify for trastuzumab, the peptide is a peptide-based immunotherapy designed to reduce breast cancer recurrence rates.
Disclaimer: Data is collected from third-party platforms, provided for reference only, and does not constitute any form of investment advice or guarantee.
